Glenmark gets nod to acquire 100% stake in Zorg

30 May 2018 Evaluate

Glenmark Pharmaceuticals has received an approval for the draft share purchase agreement to acquire 100% stake in Zorg Laboratories (Zorg) for an aggregate consideration of Rs 5 lakh before adjustments and subject to legal and financial due diligence. The meeting of the Board of Directors of the company held on May 29, 2018, approved the same.

Zorg Laboratories is engaged in the business of dealing, distributing and marketing of all types of pharmaceutical and chemical products.

Glenmark Pharmaceuticals is a global pharmaceutical company. The company is engaged in the development of new chemical entities (NCEs) and new biological entities (NBEs). Its segments are India, United States, Latin America, Europe and Rest of the World (ROW).

Glenmark Pharma Share Price

1970.75 -25.15 (-1.26%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×